Abstract:Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is increasingly recognized in older patients. The differences in disease presentation and outcome between older and younger patients remain controversial. We conducted the current study to analyze the characteristics of patients aged over 65 years with AAV and to compare the younger and older cohorts. We recruited 234 consecutive Chinese patients with AAV. We compared clinical and pathologic characteristics as well as outcomes between younger and older patients. Among the 234 patients with AAV, 99 were older than 65 years. Compared with the 135 younger patients, the older patients had a significantly higher proportion of positive myeloperoxidase-ANCA (94.9% vs. 80.0%, p < 0.01) and a higher proportion of microscopic polyangiitis (79.8% vs. 50.4%, χ2 = 11.8, p < 0.001), but had a lower proportion of Wegener granulomatosis (18.2% vs. 37.8%, p < 0.01) and renal-limited vasculitis (0% vs. 11.1%, p < 0.001). Older patients had more prevalent and severe pulmonary involvement than younger patients, including pulmonary infiltration, interstitial fibrosis, and mechanical ventilation dependence at presentation (47.5% vs. 31.9%, p < 0.05; 37.4% vs. 18.5%, p < 0.01; and 9.1% vs. 1.5%, p < 0.05, respectively). Older patients were less likely to respond to treatment (p < 0.01) and had worse survival than younger patients (p = 0.000). During follow-up, older patients had a higher risk of secondary pulmonary infection (p < 0.001), and those with pulmonary interstitial fibrosis were more likely to develop secondary pulmonary infections (p < 0.05). In conclusion, compared with younger patients, older patients with AAV had more severe and more prevalent pulmonary lesions, which might contribute to subsequent pulmonary infections after the initiation of immunosuppressive therapy. Age and pulmonary infection were independent predictors of death. Abbreviations: ANCA = antineutrophil cytoplasmic autoantibodies, AAV = ANCA-associated vasculitis, CI = confidence intervals, CRP = C-reactive protein, CSS = Churg-Strauss syndrome, CTX = cyclophosphamide, ELISA = enzyme-linked immunosorbent assay, ENT = ear, nose, and throat, ESR = erythrocyte sedimentation rate, GBM = glomerular basement membrane, HR = hazard ratio, MPA = microscopic polyangiitis, MPO = myeloperoxidase, PR3 = proteinase 3, WG = Wegener granulomatosis.

Analysis of the Causes of Death in Patients with ANCA Associated Systemic Vasculitis

Pathogenesis and treatment progress of antineutrophil cytoplasmic antibody-associated vasculitis

Clinical manifestations in elderly patients with ANCA-related vasculitis

Clinical feature analysis of 24 cases ANCA associated vasculitis

Clinical Analysis of ANCA Associated Vasculitis with Pulmonary Damage in 11 Cases

Predictors for Mortality in Patients with Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis: A Study of 398 Chinese Patients

Pathological Classification and Prognosis of Renal Damage Caused by Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Clinical Feature Analysis of 190 Patients with Anti-Neutrophil Cytoplasmic Antibodies Associated Vasculitis

Prognosis and Risk Factors of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients on Maintaining Dialysis

Cinical and Pathological Characteristics of Chinese Patients with Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitides: A Study of 426 Patients from A Single Centre

The Clinical and Pathological Characteristics of Chinese Elderly Patients with Anti-Neutrophil Cytoplasmic Autoantibodies Associated Small Vessel Vasculitis

Predictors for Outcomes in Patients with Severe ANCA-associated Glomerulonephritis Who Were Dialysis-dependent at Presentation: A Study of 89 Cases in a Single Chinese Center

Clinical and Pathological Characteristics and Outcomes of Chinese Patients with Primary Anti‐neutrophil Cytoplasmic Antibodies‐associated Systemic Vasculitis with Immune Complex Deposition in Kidney

Diagnosis and management of ANCA-associated vasculitis

Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Spectrum of Disease in Patients with Positive Antineutrophil Cytoplasmic Antibodies in General Hospitals

Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Older Patients

Clinicopathological Features of Antineutrophil Cytoplasmic Antibodies Associated Vasculitis with Glomerular IgA Deposits

An analysis of multi-system involvement and renal pathology of anti-neutrophil cytoplasmic autoantibodies-related vasculitis]

[Clinical and Coronary Angiographic Features of Patients with Systemic Vasculitis and Coronary Artery Disease].

Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis